Navigation Links
New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy
Date:1/14/2009

American Heart Association rapid access journal report:

Study highlights:

  • A new analysis estimates more than 11 million older Americans could be newly eligible for statin therapy if findings from the JUPITER trial are adopted into guidelines.
  • That could take the number of older adults eligible for statin therapy to over 44 million, or 80 percent of that population.
  • The analysis highlights a public health challenge since, even under current treatment guidelines, fewer than half of older Americans who qualify for statin therapy actually get it.
  • More analysis of the JUPITER data will be needed before findings are put into practice.

DALLAS , Jan. 14 /PRNewswire-USNewswire/ -- Researchers estimate more than 11 million older Americans may be newly eligible for statin therapy if findings from a recently published large clinical trial are adopted into clinical practice guidelines, according to a new analysis of the trial data. The analysis is published online in Circulation: Cardiovascular Quality and Outcomes.

Using data from the 1999-2004 National Health and Nutrition Examination Survey, researchers found that 33.5 million older Americans (men age 50 years and older and women age 60 years and older) are currently taking a statin (24.4 percent) or have risks that would indicate a need for statin therapy based on current guidelines but do not take a statin (33.5 percent).

They estimated that an additional 19.2 percent of older adults could be considered eligible for statin therapy based on their matching the inclusion criteria used in a recently published clinical trial, Justification for the Use of statins in Primary prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER), presented in November at the American Heart Association's Scientific Sessions 2008 in New Orlean
'/>"/>

SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NicOx Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis
2. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
3. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
4. New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity
5. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
6. Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
7. Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
8. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
9. Fralex provides update on timing of interim analysis results
10. Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
11. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...if., Nov. 30 StemCyte, Inc. conclu...eement with Academia Sinica, the National Laborato...Intellectual Property (IP) related to the treatmen...and IP was pioneered by a team led by Professor Jo...rofessor Lin is currently the exclusive collaborat...
(Date:11/30/2009)...LLS, Mich., Nov. 30 eHealthSource....ted exclusively to products approved for Flexible ...A) claims. The site is also the first to exclusiv...s, saving shoppers up to 75 percent on everyday he...wo common healthcare headaches - high costs and co...
(Date:11/30/2009)... Italy, November 30 Health Robotic... development plans and product specifications,for ...d Parenteral,Nutrition", a new key component of it...t Las Vegas, ASHP (Booth # 114). , "I loo...o the,TPNstation,s blueprints and to find out if T...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3China Kangtai Cactus Biotech to Attend Rodman 26 Renshaw Conference and Meet with Investors in September 55140 1China Kangtai Cactus Biotech to Attend Rodman 26 Renshaw Conference and Meet with Investors in September 55140 2China Kangtai Cactus Biotech to Attend Rodman 26 Renshaw Conference and Meet with Investors in September 55140 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 1MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 2MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 3MEDRAD Partners with the University of South Florida and Moffitt Cancer Center to Study Workflow and Process Improvements in PET Imaging 13666 4Obama Named the Most Powerful Person in Healthcare 55134 1Obama Named the Most Powerful Person in Healthcare 55134 2
...tes Presented at the,67th Annual Scientific Sessio..., June 25, 2007 /PRNewswire/ -- DiObex, Inc., a,pr...the development,of therapeutics to treat metabolic... line data of its phase 2a study of DIO-902, a,fir...e treatment of,type 2 diabetes. , Results of the t...
...- Neurogen,Corporation (Nasdaq: NRGN) today announ...g, Phase 2b clinical trials in chronic,insomnia pa...nt,NG2-73, an alpha-3 preferring GABA(A) partial ...h trial to determine the best,profile for rapidity...he night without residual sedation the next day., ...
Other Medicine Technology:DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of,Improved Glycemic Control and Significant Reductions of,LDL-Cholesterol and C-Reactive Protein 2DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of,Improved Glycemic Control and Significant Reductions of,LDL-Cholesterol and C-Reactive Protein 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 2Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 3Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 4Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 5Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 6Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 7Neurogen Announces Positive Results for Proprietary Insomnia Drug,in Two Chronic Insomnia Clinical Trials 8
(Date:11/30/2009)...;My Two-Year Old Eats Octopus," gives mealtim...hing. , (PRWEB) November ...e? Do you find yourself acting as a short-order c...dash; one focusing on packing lunches, a second on...ife parents’ questions – introduce use...
(Date:11/30/2009)... do knees, internal injuries, study finds, , ...,re a middle-age weekend warrior who likes to hit ...new study suggests that high levels of physical ac... could lead to osteoarthritis. , The study foun...who showed no symptoms and had a healthy weight. T...
(Date:11/30/2009)... 30 /PRNewswire-FirstCall/ - Hard to Treat Disease... subsidiary Mellow Hope finalized contract details...us medication in India. This contract promises add...eases in the following quarters. ,, The contrac...supply of raw pharmaceutical material to the India...
(Date:11/30/2009)... giving catalog to help families make charitable g.... 30 In spite of the ec...ay season willing to support charities in two ways...own wallets to support charities and nearly 40 per... instead of buying them a gift, according to a new...
(Date:11/30/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Gene Therapy - Worldwide Market Challen...inker.com/p0164218/Gene-Therapy---Worldwide-Market...py promises to be one of the most important fronti...nts for curing disease have been achieved, the fut...
Breaking Medicine News(10 mins):Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 3Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 2Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 3Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 4Health News:Reportlinker Adds Gene Therapy - Worldwide Market Challenges & Opportunities 5
...tious Diseases brings together leading health ex...cent of Americans, ...he U.S. Enough vaccine, will be available so that... getting their flu ...
...merican Society of,Transplantation (AST) is hittin... to a unique target audience -- human resource pro...chapters of the Society of Human,Resource Manageme...leave policies for employees who act as live organ...
...ys to deliver healthcare to patients is key to ens...he nation,s baby boomers according to a new paper ...fairs . , The good news, as the paper points out,...providers when better care is delivered, increase ...
...ria that drive the ailment, study shows , ...y help bring sweet relief to chronic sinusitis suf...ts say natural germ fighters in honey attack the b... for hundreds of years," noted study co-author Dr....
...me, accumulated data,demonstrates that women diagn...n and uterine (endometrial) cancers, experience im...c oncologist. The 2008 State of the State,of Gynec... oncologists are physicians committed to the compr...
...prove Care for the Sick & Elderly at ...T, Calif., Sept. 24 More than 700 healthcare,work...ednesday morning to,protest Windsor Healthcare Man...sponded by informing workers that,they will lock t...
Other Medicine News:Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 2Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 3Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 4Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 5Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 6Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 7Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 8Health News:Video: Influenza Vaccine Recommended for More Americans Than Ever Before 9Health News:AST to Address Human Resources Groups Nationwide to Encourage them to Adopt a Paid Leave Plan for Organ Donors 2Health News:Geisinger study: Increasing health care value improves health care quality 2Health News:A Honey of a Sinusitis Treatment 2Health News:A Honey of a Sinusitis Treatment 3Health News:Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist 2Health News:Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist 3Health News:Caregivers Hold Unfair Labor Practice Strike to Improve Quality of Resident Care at Statewide Nursing Home Chain 2Health News:Caregivers Hold Unfair Labor Practice Strike to Improve Quality of Resident Care at Statewide Nursing Home Chain 3
...ve PoleStar N20, exclusively distributed by Medtro...ombining intra-operative imaging with surgical nav...PoleStar N20 is one of the most comprehensive neur...al image quality from a low-field magnet , Super...
PTH (Intact) Mircrowell-IRMA
...ingle Use Loading Units with Stainless Steel Stapl..., ,Utilizing a disposable loading unit, the LDS-2...s to ligate the tissue within the cartridge jaw an...wo closed clips. The instrument is activated by sq...
LIGACLIP ERCA Endoscopic Rotating Multiple Clip and Applier
Medicine Products: